While trials with decentralized attributes have grown, we are still in the early stages of adapting trial design strategies to better fit this new reality. This white paper explores the current DCT landscape and its evolution over time, as well as the key advantages of incorporating decentralized attributes and how barriers to their inclusion can be overcome.

You can also download the PDF by clicking the button below

We need to make trials fit around lives rather than lives fit around trials.
Wendi Lau, Senior Director of Clinical Development Operations, AbbVie

Related Resources

OCT 11, 2023

Decentralized Clinical Trials - Meeting Patients Where They’re At

Decentralized clinical trials are one example of how the research community is working to make trials as accessible as possible.

JUL 03, 2023

Medtech Connect Podcast Episode 7 – Decentralized Clinical Trials

Decentralized clinical trial experts discuss the draft FDA guidance, what might need clarification, and what changes they expect as DCTs become mainstream.

SEP 06, 2023

Technology & the Triple Aim of Trial Recruiting

The search for a clinical trial match has led patients and caregivers online. All stakeholders must be connected and vetted via available technology.